Introduction
============

In 2012, more than 25% of US adults reported having 2 or more chronic conditions, which increased from 22% in 2001 ([@R1],[@R2]). Because of this increase, the Department of Health and Human Services (DHHS) formed the Multiple Chronic Conditions Working Group to compile a list of chronic conditions to improve disease management and quality of life for people with chronic comorbid conditions ([@R3],[@R4]).

People with multiple chronic conditions face health care burdens because of the complexity of coordinating disease management, including treatment by medical professionals and self-care ([@R3]). Prior studies show that people with chronic conditions ([@R5]--[@R14]) often use complementary and alternative medicine (CAM) therapies as part of disease management. CAM therapies refer to a number of approaches not part of mainstream conventional medicine, used either in complement with or in lieu of standard medical treatments ([@R15]). Studies to date suggest that people with chronic conditions are more likely to use CAM, and people with additional conditions have an increased likelihood of overall CAM use ([@R5],[@R7],[@R8],[@R9],[@R11],[@R16]--[@R18]). However, one study among patients with chronic liver disease showed an inverse association between additional comorbidities and current CAM use ([@R19]).

The aim of this study was to determine the association between use of CAM therapies and multiple chronic conditions in a large nationally representative population of US adults. To our knowledge, no studies have examined specific CAM therapy use with comorbid conditions. Studies examining comorbid conditions and CAM use have collapsed CAM into any use versus no use, whereas in reality, CAM therapies represent a heterogeneous group of behaviors that differ in type, usage, and bodies of evidence on efficacy. Understanding use of specific CAM modalities among people with multiple chronic conditions could increase knowledge about CAM therapies and disease management.

Methods
=======

The 2012 National Health Interview Survey (NHIS) ([@R20]) is a cross-sectional household survey conducted annually by the Centers for Disease Control and Prevention of the US noninstitutionalized, civilian population. The NHIS uses a complex sampling procedure to obtain a nationally representative sample ([@R21]). Since 2002 and every 5 years thereafter, the NHIS has included a survey supplement on CAM use. The 2012 NHIS data set included 34,525 adults (people aged 18 or older). People were excluded from this analysis if they had missing data on all CAM variables (n = 968), leaving a final sample size of 33,557.

The number of chronic conditions was calculated by using the list developed by the Multiple Chronic Conditions Working Group ([@R4]). Of the 20 chronic conditions listed by the working group, 13 conditions were ascertained in the NHIS 2012 interview ([@R4],[@R20]). The chronic condition variables selected from the 2012 data set were those that best reflected the definition of a chronic condition ([@R4]). Participants self-reported having ever been told by a physician they had the following conditions: hypertension 2 times or more, cancer (excluding nonmelanoma skin cancer), chronic obstructive pulmonary disease (COPD, emphysema, or chronic bronchitis in the past 12 months), diabetes, hepatitis, coronary heart disease (CHD), stroke, arthritis, depression, high cholesterol; and any of the following conditions in the past 12 months: asthma attack, weak or failing kidneys, or substance abuse ([@R20]). In 2012, because of the CAM supplement being included in the NHIS, additional conditions were assessed that are on the DHHS list but not usually ascertained, including high cholesterol, depression, and substance abuse. A composite variable summed the number of chronic conditions each subject reported (range, 0--13). It was conservatively assumed that any missing value for a single condition would be recoded as a "no" response. The composite variable was categorized into 3 levels: none, 1, and 2 or more of the 13 selected chronic conditions.

The NHIS contains dichotomous (yes/no) information on use of 20 different CAM therapies: body-based therapies including chiropractic or osteopathic manipulation, massage, acupuncture, and movement therapy; mind--body therapies including yoga, tai chi, qi gong, energy healing therapy, hypnosis, and biofeedback; alternative therapies including Ayurvedic medicine, chelation therapy, craniosacral therapy, homeopathy, naturopathy, and traditional healing; dietary supplements including vitamins, minerals, multivitamin or multimineral, and other nonvitamin or herbal therapies; and special diets. Energy healing therapy, biofeedback, hypnosis, yoga, tai chi, qi gong, and mind--body therapies such as guided relaxation were collapsed into one mind--body therapy variable because they are similar behavioral CAM therapies. Therefore, this analysis examined 16 dichotomous CAM therapy outcome variables, defined as using a therapy or seeing a practitioner for the modality or both in the past 12 months. A CAM use index was created by summing the number of CAM therapies each individual used (range, 0--16). It was assumed that any missing value for a single therapy would be recoded as a "no" response.

The definition of CAM therapies is largely based on the classifications of the National Center for Complementary and Integrative Health ([@R15]), though these analyses also include the use of vitamins, minerals, and multivitamins because of their high prevalence of use. The inclusion of vitamins, minerals, and multivitamins in the definition of CAM varies in the literature. More than 50% of the US population uses dietary supplements including multivitamins or minerals and singular vitamin and mineral supplements, and this use has increased over the past 20 years ([@R22]). Because use is so widespread and the risk for supplements to interact with standard pharmaceutical treatments is high ([@R23]), it is important to describe all supplement use. Therefore, we analyzed these individual therapies and 3 CAM indices; all CAM, excluding multivitamins or minerals, and further excluding singular vitamin and mineral supplements.

Demographic and psychosocial characteristics were examined for confounding effects. A priori confounders included respondent-reported race/ethnicity, sex, age, employment status in the previous year (yes/no), imputed family income, and highest level of education. Hypothesized confounders included region, body mass index (BMI), marital status, and the following in the past 12 months: feeling frequently stressed and/or anxious (yes/no), perceived health status (fair or poor vs excellent to good), and fatigue (yes/no).

Frequencies analysis and bivariable and multivariable analyses were performed to assess the association between the presence of multiple chronic conditions and CAM use. Each CAM therapy was analyzed in separate unadjusted and adjusted Poisson regression models with a robust error variance that estimated the relative risk of CAM use, comparing participants with 1 and 2 or more chronic conditions with participants with no chronic conditions (the reference group). Bonferroni procedures ([@R24]) were used to account for multiple comparisons; the standard α level of 5% was divided by 17 (the total number of specific CAM therapies plus the CAM index) to create a corrected α level of .003. Data on chelation therapy was not shown because of the small sample size (n = 17). The relationship between the CAM index and multiple chronic conditions was determined by using a linear regression model adjusted for confounders. Confounders to be included in the final models were identified by using the minimally adjusted models, which included all a priori confounders. Hypothesized confounders were added to minimally adjusted models for all of the separate CAM outcomes. The variables that appreciably changed the parameter estimates by 10% were included in all of the final models. Multicollinearity of predictors was assessed for the final adjusted models by examining tolerance and variance inflation factor characteristics in a linear regression model ([@R25]). Tolerance and variance inflation factors are statistical values that describe the percentage by which 1 predictor is explained by the other predictors in the model. Values of tolerance below 10% and variance inflation factor above 10 indicate potential collinearity. Missing covariates were not imputed and were excluded from individual regression models. All regression analyses were weighted on the basis of the complex NHIS sampling survey procedure ([@R26]), using SAS software version 9.3 (SAS Institute Inc).

Results
=======

Chronic conditions were common in the US population as sampled in the 2012 NHIS, where 22.3% of adults reported 1 condition and 33.8% reported 2 or more conditions; therefore, more than half (56.1%) reported at least 1 chronic condition ([Table 1](#T1){ref-type="table"}). Of the participants with 2 or more chronic conditions, most had 2 conditions (42.3%), followed by 3 (27.5%) and 4 (15.9%) conditions (data not shown). The average age of participants was 48 years and most adults were non-Hispanic white (67.2%), female (51.8%), and employed (66.5%). Compared with adults with no chronic conditions, adults with multiple chronic conditions were older, had a lower income, were less educated, were unemployed, were more likely to be obese, and reported having worse perceived health status and being frequently stressed or anxious.

###### Population Characteristics by Number of Chronic Conditions, National Health Interview Survey, 2012

  Characteristic                     No. of Chronic Conditions   *P* [b](#T1FN2){ref-type="table-fn"}                                                                                         
  ---------------------------------- --------------------------- -------------------------------------- -------- ------------------- ------- ------------------- -------- ------------------- --------
  Totals                             33,557                      100 (NA)                               13,790   43.9 (43.1--44.6)   7,427   22.3 (21.7--22.9)   12,340   33.8 (33.1--34.5)   NA
  **Race/ethnicity**                                                                                                                                                                          
  Hispanic                           5,738                       15.0 (14.3--15.7)                      3,155    20.0 (18.9--21.0)   1,204   13.9 (12.9--14.8)   1,379    9.4 (8.7--10.0)     \<.001
  Non-Hispanic white                 20,277                      67.2 (66.3--68.1)                      7,272    59.8 (58.5--61.0)   4,711   70.1 (68.9--71.4)   8,294    75.0 (73.9--76.0)   
  Non-Hispanic black                 5,101                       11.8 (11.2--12.3)                      2,043    12.6 (11.9--13.3)   1,060   10.8 (10.0--11.7)   1,998    11.3 (10.5--12.1)   
  Asian                              2,078                       5.2 (4.9--5.5)                         1,164    6.9 (6.4--7.5)      386     4.5 (4.0--5.1)      528      3.4 (3.0--3.9)      
  Other race                         363                         0.8 (0.6--1.0)                         156      0.8 (0.6--1.0)      66      0.6 (0.4--0.9)      141      0.9 (0.7--1.2)      
  **Age group, y**                                                                                                                                                                            
  18--24                             3,329                       12.9 (12.3--13.5)                      2,549    22.7 (21.6--23.8)   590     10.1 (9.0--11.1)    190      2.1 (1.6--2.5)      \<.001
  25--34                             5,955                       17.6 (17.0--18.2)                      4,077    27.7 (26.8--28.7)   1,269   16.4 (15.3--17.5)   609      5.2 (4.7--5.7)      
  35--44                             5,611                       16.9 (16.4--17.5)                      3,081    21.5 (20.6--22.4)   1,434   19.3 (18.1--20.5)   1,096    9.4 (8.7--10.1)     
  45--54                             5,760                       18.6 (18.0--19.1)                      2,105    15.8 (15.0--16.6)   1,531   22.5 (21.3--23.7)   2,124    19.6 (18.7--20.5)   
  55--64                             5,728                       16.3 (15.8--16.8)                      1,213    7.8 (7.3--8.3)      1,304   17.4 (16.3--18.6)   3,211    26.5 (25.3--27.6)   
  ≥65                                7,174                       17.8 (17.2--18.3)                      765      4.4 (4.0--4.8)      1,299   14.3 (13.3--15.4)   5,110    37.3 (36.2--38.4)   
  **Sex**                                                                                                                                                                                     
  Male                               14,858                      48.2 (47.4--48.9)                      6,502    50.6 (49.5--51.6)   3,234   47.6 (46.0--49.1)   5,122    45.5 (44.4--46.6)   \<.001
  Female                             18,699                      51.8 (51.1--52.6)                      7,288    49.4 (48.4--50.5)   4,193   52.4 (50.9--54.0)   7,218    54.5 (53.4--55.6)   
  **Marital status**                                                                                                                                                                          
  Divorced or separated              6,305                       13.5 (13.0--13.9)                      1,958    10.1 (9.6--10.7)    1,399   13.4 (12.6--14.3)   2,948    17.8 (17.1--18.6)   \<.001
  Married                            14,583                      53.2 (52.4--53.9)                      5,879    48.5 (47.4--49.6)   3,406   56.5 (55.0--58.1)   5,298    57.0 (55.9--58.2)   
  Single                             9,333                       27.1 (26.4--27.8)                      5,526    39.7 (38.6--40.9)   2,009   24.9 (23.6--26.1)   1,798    12.3 (11.6--13.0)   
  Widowed                            3,257                       6.2 (5.9--6.5)                         389      1.7 (1.5--1.9)      592     5.2 (4.6--5.7)      2,276    12.8 (12.1--13.5)   
  **Region**                                                                                                                                                                                  
  Northeast                          5,617                       18.2 (17.5--18.9)                      2,302    18.9 (17.8--19.9)   1,292   18.9 (17.5--20.2)   2023     16.9 (16.0--17.8)   \<.001
  Midwest                            6,967                       22.7 (21.9--23.5)                      2,783    22.0 (21.0--23.1)   1,615   23.5 (22.1--24.9)   2,569    23.1 (21.9--24.4)   
  South                              12,184                      36.4 (35.5--37.3)                      4,848    35.2 (34.0--36.4)   2,566   35.0 (33.5--36.5)   4,770    38.9 (37.5--40.2)   
  West                               8,789                       22.7 (21.8--23.5)                      3,857    23.9 (22.8--25.0)   1,954   22.7 (21.3--24.0)   2,978    21.1 (20.0--22.2)   
  **Employment status**                                                                                                                                                                       
  Employed                           21,412                      66.5 (65.7--67.3)                      10,817   78.1 (77.2--79.1)   5,235   72.4 (71.0--73.9)   5,360    47.5 (46.3--48.7)   \<.001
  Unemployed                         12,121                      33.5 (32.7--34.3)                      2,961    21.9 (20.9--22.8)   2,188   27.6 (26.1--29.0)   6,972    52.5 (51.3--53.7)   
  **Imputed family income, \$**                                                                                                                                                               
  0--34,999                          13,936                      33.5 (32.6--34.4)                      5,376    31.7 (30.5--33.0)   2,747   28.9 (27.4--30.3)   5,813    38.7 (37.5--40.0)   \<.001
  35,000--74,999                     9,673                       31.9 (31.2--32.7)                      4,028    31.6 (30.5--32.6)   2,193   31.8 (30.3--33.2)   3,452    32.5 (31.3--33.7)   
  75,000--99,999                     3,186                       12.3 (11.8--12.9)                      1,396    12.7 (11.9--13.5)   770     13.6 (12.5--14.7)   1,020    11.0 (10.2--11.9)   
  ≥100,000                           4,963                       22.3 (21.4--23.1)                      2,252    24.0 (22.8--25.2)   1,330   25.8 (24.2--27.3)   1,381    17.7 (16.5--18.9)   
  **Education**                                                                                                                                                                               
  ≤High school diploma               14,012                      40.2 (39.4--41.0)                      5,285    37.6 (36.5--38.7)   2,876   37.6 (36.2--39.0)   5,851    45.3 (44.0--46.6)   \<.001
  Some college or associate degree   10,290                      31.3 (30.5--32.1)                      4,288    31.7 (30.5--32.8)   2,320   31.4 (30.1--32.7)   3,682    30.8 (29.6--31.9)   
  Bachelor's degree                  5,838                       18.5 (17.9--19.0)                      2,776    21.0 (20.1--21.9)   1,401   19.5 (18.4--20.6)   1,661    14.5 (13.6--15.3)   
  Graduate or professional degree    3,282                       10.0 (9.5--10.5)                       1,375    9.7 (9.0--10.4)     811     11.5 (10.6--12.4)   1,096    9.5 (8.7--10.2)     
  **Body mass index, kg/m^2^**                                                                                                                                                                
  \<25.0                             11,852                      36.6 (35.9--37.3)                      6,139    46.2 (45.0--47.4)   2,597   36.1 (34.7--37.5)   3,116    24.5 (23.6--25.4)   \<.001
  25.0--29.9                         11,268                      34.9 (34.2--35.6)                      4,473    33.3 (32.2--34.3)   2,578   35.4 (34.1--36.8)   4,217    36.5 (35.5--37.6)   
  ≥30.0                              9,434                       28.5 (27.9--29.2)                      2,740    20.5 (19.6--21.4)   2,046   28.5 (27.1--29.9)   4,648    39.0 (37.9--40.1)   
  **Perceived health status**                                                                                                                                                                 
  Fair or poor                       5,082                       12.9 (12.4--13.3)                      565      3.5 (3.1--3.8)      719     8.3 (7.6--9.0)      3,798    28.1 (27.0--29.2)   \<.001
  Excellent to good                  28,461                      87.1 (86.7--87.6)                      1,3221   96.5 (96.2--96.9)   6,705   91.7 (91.0--92.4)   8,535    71.9 (70.8--73.0)   
  **Frequent stress and anxiety**                                                                                                                                                             
  No                                 22,690                      68.3 (67.6--69.0)                      10,838   78.6 (77.6--79.6)   4,863   64.9 (63.4--66.3)   6,989    57.2 (56.0--58.5)   \<.001
  Yes                                10,846                      31.7 (31.0--32.4)                      2,941    21.4 (20.4--22.4)   2,562   35.1 (33.7--36.6)   5,343    42.8 (41.5--44.0)   
  **Fatigue**                                                                                                                                                                                 
  No                                 28,165                      84.6 (84.1--85.1)                      12,986   94.1 (93.7--94.6)   6,377   85.6 (84.5--86.6)   8,802    71.7 (70.6--72.7)   \<.001
  Yes                                5,374                       15.4 (14.9--15.9)                      798      5.9 (5.4--6.3)      1,049   14.4 (13.4--15.5)   3,527    28.3 (27.3--29.4)   

Abbreviations: CI, confidence interval; NA, not applicable.

Each n reported in the table is not weighted, but all percentages are weighted.

Rao-Scott χ^2^ tests were used to assess associations between population characteristics and number of chronic conditions.

CAM use was common in the US population. The 4 most frequently used therapies in the past year were multivitamins (52.7%), vitamins (34.8%), minerals (28.4%), and nonvitamin or herbal therapies (17.9%) ([Table 2](#T2){ref-type="table"}). Adults with multiple chronic conditions reported using on average 2.0 CAM therapies in the last year. Compared with adults with 1 condition or no chronic conditions, adults with multiple chronic conditions reported higher frequency of multivitamin or multimineral use (57.1%), vitamins (42.8%), minerals (37.5%), nonvitamin or herbal therapies (22.0%), chiropractic or osteopathic manipulation (10.1%), massage (9.7%), special diets (3.6%), and acupuncture (1.9%). Conversely, adults with multiple chronic conditions reported using mind--body and movement therapy less often than those with no chronic conditions or one chronic condition ([Table 2](#T2){ref-type="table"}).

###### Use of CAM in the Past 12 Months by Number of Chronic Conditions, National Health Interview Survey, 2012

  CAM Index, Mean (SE)                             Total Study Population (n = 33,557)   0 Chronic Conditions (n = 13,790)            1 Chronic Condition (n = 7,427)   ≥2 Chronic Conditions (n = 12,340)           *P* [b](#T2FN2){ref-type="table-fn"}                                                                                                     
  ------------------------------------------------ ------------------------------------- -------------------------------------------- --------------------------------- -------------------------------------------- -------------------------------------- -------------------------------------------- ------- -------------------------------------------- -----------------------------------------
  All CAM                                          1.8                                   1.8--1.8 (0.02)                              1.5                               1.5--1.6 (0.02)                              1.9                                    1.9--2.0 (0.03)                              2.0     2.0--2.1 (0.02)                              \<.001
  Excluding multivitamins                          1.3                                   1.2--1.3 (0.01)                              1.0                               1.0--1.1 (0.02)                              1.4                                    1.3--1.4 (0.02)                              1.5     1.4--1.5 (0.02)                              \<.001
  Excluding multivitamins, vitamins and minerals   0.6                                   0.6--0.7 (0.01)                              0.6                               0.5--0.6 (0.01)                              0.7                                    0.7--0.7 (0.02)                              0.7     0.6--0.7 (0.02)                              \<.001
  **Specific CAM therapies**                       **N**                                 **% (CI)[a](#T2FN1){ref-type="table-fn"}**   **n**                             **% (CI)[a](#T2FN1){ref-type="table-fn"}**   **n**                                  **% (CI)[a](#T2FN1){ref-type="table-fn"}**   **n**   **% (CI)[a](#T2FN1){ref-type="table-fn"}**   ***P*[b](#T2FN2){ref-type="table-fn"}**
  Multivitamin or multimineral                     17,493                                52.7 (52.0--53.5)                            6,628                             48.4 (47.2--49.6)                            3,985                                  54.6 (53.2--56.0)                            6,880   57.1 (55.9--58.2)                            \<.001
  Vitamin                                          11,662                                34.8 (34.0--35.6)                            3,751                             27.6 (26.6--28.6)                            2,670                                  36.8 (35.3--38.3)                            5,241   42.8 (41.5 --44.1)                           \<.001
  Mineral                                          9,891                                 28.4 (27.7--29.2)                            2,979                             21.0 (20.1--21.9)                            2,225                                  29.3 (27.9--30.8)                            4,687   37.5 (36.3-- 38.7)                           \<.001
  Nonvitamin or herbal therapies                   5,974                                 17.9 (17.2--18.6)                            1,925                             13.6 (12.8--14.4)                            1,431                                  20.0 (18.8--21.3)                            2,618   22.0 (20.8--23.1                             \<.001
  Mind--body therapy                               4,127                                 12.5 (11.9--13.0)                            1,771                             12.8 (12.1--13.6)                            1,006                                  13.9 (12.9--15.0)                            1,350   11.0 (10.3 --11.7)                           \<.001
  Chiropractic or osteopathic manipulation         2,993                                 9.1 (8.7--9.5)                               991                               7.5 (6.9--8.1)                               776                                    10.7 (9.8--11.6)                             1,226   10.1 (9.4--10.8)                             \<.001
  Massage                                          2,951                                 8.8 (8.4--9.2)                               1,094                             7.8 (7.2--8.4)                               716                                    9.4 (8.6--10.3)                              1,141   9.7 (9.0--10.4)                              \<.001
  Movement therapy                                 2,162                                 6.6 (6.2--7.0)                               974                               7.2 (6.5--7.8)                               584                                    7.8 (7.1--8.5)                               604     5.0 (4.5--5.6)                               \<.001
  Special diets                                    1,027                                 3.0 (2.8--3.3)                               341                               2.4 (2.0--2.7)                               266                                    3.4 (2.9--4.0)                               420     3.6 (3.1--4.1)                               \<.001
  Homeopathy                                       718                                   2.2 (2.0--2.4)                               270                               2.1 (1.8--2.4)                               185                                    2.6 (2.1--3.1)                               263     2.1 (1.8--2.5)                               .1
  Acupuncture                                      604                                   1.6 (1.4--1.8)                               196                               1.3 (1.1--1.5)                               142                                    1.8 (1.4--2.1)                               266     1.9 (1.6--2.2)                               .002
  Naturopathy                                      276                                   0.7 (0.6--0.8)                               96                                0.6 (0.5--0.8)                               75                                     0.7 (0.5--1.0)                               105     0.9 (0.7--1.0)                               .15
  Traditional healing                              170                                   0.4 (0.4--0.5)                               67                                0.5 (0.3--0.6)                               35                                     0.4 (0.2--0.5)                               68      0.5 (0.3--0.6)                               .70
  Craniosacral therapy                             109                                   0.3 (0.2--0.4)                               37                                0.3 (0.2--0.4)                               25                                     0.2 (0.1--0.3)                               47      0.3 (0.2--0.5)                               .50
  Ayurvedic medicine                               96                                    0.3 (0.2--0.3)                               45                                0.3 (0.2--0.5)                               25                                     0.2 (0.1--0.3)                               26      0.2 (0.1--0.3)                               .10

Abbreviations: CAM, complementary and alternative medicine; CI, confidence interval; SE, standard error.

Each n reported in the table is not weighted, but all averages and percentages are weighted.

*P* values for association between CAM therapies and number of chronic conditions. Rai-Scott χ^2^ tests and univariable linear regression models used for categorical and continuous variables, respectively.

After controlling for a priori confounders of age, sex, race, family income, employment status, and education, adults with 2 or more chronic conditions were more likely than adults with no chronic conditions to report using multivitamins/minerals, minerals, vitamins, nonvitamin or herbal therapies, mind--body therapies, chiropractic or osteopathic manipulation, massage, and special diets ([Table 3](#T3){ref-type="table"}). In models adjusted for additional confounding factors, the relationships persisted in all outcome models, and the positive association between multiple chronic conditions and use of movement therapy, acupuncture, and naturopathy became significant ([Table 3](#T3){ref-type="table"}).

###### Association Between CAM Use and Number of Chronic Conditions, National Health Interview Survey, 2012

  CAM Modality Outcome Measures[a](#T3FN1){ref-type="table-fn"}                                                                                                                                                                                                                                
  ------------------------------------------------------------------------- ------------------------------------- -------------------------------------- ------------- ------------------------------------- ------------------------------------- ----- ------------------------------------- -------------------------------------
  **CAM indexes, β coefficient (95% CI)[d](#T3FN4){ref-type="table-fn"}**                                                                                                                                                                                                                      
  All CAM                                                                                                                                                                                                                                                                                      
  Ref                                                                       0.4[e](#T3FN5){ref-type="table-fn"}   0.5[e](#T3FN5){ref-type="table-fn"}    Ref           0.3[e](#T3FN5){ref-type="table-fn"}   0.6[e](#T3FN5){ref-type="table-fn"}   Ref   0.3[e](#T3FN5){ref-type="table-fn"}   0.6[e](#T3FN5){ref-type="table-fn"}
  (0.3--0.4)                                                                (0.5--0.6)                            (0.3--0.4)                             (0.5--0.6)    (0.3--0.4)                            (0.6--0.7)                                                                        
  Excluding multivitamins/minerals                                                                                                                                                                                                                                                             
  Ref                                                                       0.3[e](#T3FN5){ref-type="table-fn"}   0.4[e](#T3FN5){ref-type="table-fn"}    Ref           0.3[e](#T3FN5){ref-type="table-fn"}   0.5[e](#T3FN5){ref-type="table-fn"}   Ref   0.3[e](#T3FN5){ref-type="table-fn"}   0.5[e](#T3FN5){ref-type="table-fn"}
  (0.3--0.4)                                                                (0.4--0.5)                            (0.2--0.3)                             (0.4--0.5)    (0.2--0.3)                            (0.5--0.6)                                                                        
  Excluding multivitamins, vitamins, and minerals                                                                                                                                                                                                                                              
  Ref                                                                       0.1[e](#T3FN5){ref-type="table-fn"}   0.1[e](#T3FN5){ref-type="table-fn"}    Ref           0.1[e](#T3FN5){ref-type="table-fn"}   0.2[e](#T3FN5){ref-type="table-fn"}   Ref   0.1[e](#T3FN5){ref-type="table-fn"}   0.2[e](#T3FN5){ref-type="table-fn"}
  (0.1--0.2)                                                                (0.1--0.1)                            (0.1--0.2)                             (0.2--0.2)    (0.1--0.2)                            (0.2--0.3)                                                                        
  **Specific CAM therapies, RR (95% CI)[f](#T3FN6){ref-type="table-fn"}**                                                                                                                                                                                                                      
  Multivitamin or multimineral                                                                                                                                                                                                                                                                 
  Ref                                                                       1.1[e](#T3FN5){ref-type="table-fn"}   1.2[e](#T3FN5){ref-type="table-fn"}    Ref           1.1[g](#T3FN7){ref-type="table-fn"}   1.1[e](#T3FN5){ref-type="table-fn"}   Ref   1.1[e](#T3FN5){ref-type="table-fn"}   1.2[e](#T3FN5){ref-type="table-fn"}
  (1.1--1.2)                                                                (1.1--1.2)                            (1.0--1.1)                             (1.1--1.2)    (1.0--1.1)                            (1.1--1.2)                                                                        
  Mineral                                                                                                                                                                                                                                                                                      
  Ref                                                                       1.4[e](#T3FN5){ref-type="table-fn"}   1.8[e](#T3FN5){ref-type="table-fn"}    Ref           1.2[e](#T3FN5){ref-type="table-fn"}   1.4[e](#T3FN5){ref-type="table-fn"}   Ref   1.2[e](#T3FN5){ref-type="table-fn"}   1.4[e](#T3FN5){ref-type="table-fn"}
  (1.3--1.5)                                                                (1.7--1.9)                            (1.1--1.3)                             (1.3--1.5)    (1.1--1.3)                            (1.4--1.5)                                                                        
  Vitamin                                                                                                                                                                                                                                                                                      
  Ref                                                                       1.3[e](#T3FN5){ref-type="table-fn"}   1.6[e](#T3FN5){ref-type="table-fn"}    Ref           1.2[e](#T3FN5){ref-type="table-fn"}   1.4[e](#T3FN5){ref-type="table-fn"}   Ref   1.2[e](#T3FN5){ref-type="table-fn"}   1.4[e](#T3FN5){ref-type="table-fn"}
  (1.3--1.4)                                                                (1.5--1.6)                            (1.2--1.3)                             (1.3--1.5)    (1.2--1.3)                            (1.3--1.5)                                                                        
  Nonvitamin or herbal therapies                                                                                                                                                                                                                                                               
  Ref                                                                       1.5[e](#T3FN5){ref-type="table-fn"}   1.6[e](#T3FN5){ref-type="table-fn"}    Ref           1.4[e](#T3FN5){ref-type="table-fn"}   1.7[e](#T3FN5){ref-type="table-fn"}   Ref   1.4[e](#T3FN5){ref-type="table-fn"}   1.7[e](#T3FN5){ref-type="table-fn"}
  (1.4--1.6)                                                                (1.5--1.7)                            (1.3--1.5)                             (1.5--1.8)    (1.3--1.6)                            (1.6--1.9)                                                                        
  Mind--body therapy                                                                                                                                                                                                                                                                           
  Ref                                                                       1.1[h](#T3FN8){ref-type="table-fn"}   0.9 [e](#T3FN5){ref-type="table-fn"}   Ref           1.2[e](#T3FN5){ref-type="table-fn"}   1.4[e](#T3FN5){ref-type="table-fn"}   Ref   1.3[e](#T3FN5){ref-type="table-fn"}   1.6[e](#T3FN5){ref-type="table-fn"}
  (1.0--1.2)                                                                (0.8--0.9)                            (1.1--1.4)                             (1.3--1.6)    (1.2--1.4)                            (1.4--1.7)                                                                        
  Chiropractic or osteopathic manipulation                                                                                                                                                                                                                                                     
  Ref                                                                       1.4[e](#T3FN5){ref-type="table-fn"}   1.3[e](#T3FN5){ref-type="table-fn"}    Ref           1.3[e](#T3FN5){ref-type="table-fn"}   1.4[e](#T3FN5){ref-type="table-fn"}   Ref   1.3[e](#T3FN5){ref-type="table-fn"}   1.4[e](#T3FN5){ref-type="table-fn"}
  (1.3--1.6)                                                                (1.2--1.5)                            (1.2--1.5)                             (1.2--1.6)    (1.2--1.5)                            (1.2--1.6)                                                                        
  Massage                                                                                                                                                                                                                                                                                      
  Ref                                                                       1.2[g](#T3FN7){ref-type="table-fn"}   1.2[e](#T3FN5){ref-type="table-fn"}    Ref           1.3[e](#T3FN5){ref-type="table-fn"}   1.8[e](#T3FN5){ref-type="table-fn"}   Ref   1.3[e](#T3FN5){ref-type="table-fn"}   1.9[e](#T3FN5){ref-type="table-fn"}
  (1.1--1.4)                                                                (1.1--1.4)                            (1.1--1.4)                             (1.6--2.1)    (1.2--1.5)                            (1.7--2.2)                                                                        
  Movement therapy                                                                                                                                                                                                                                                                             
  Ref                                                                       1.1[h](#T3FN8){ref-type="table-fn"}   0.7[e](#T3FN5){ref-type="table-fn"}    Ref           1.2[h](#T3FN8){ref-type="table-fn"}   1.2[h](#T3FN8){ref-type="table-fn"}   Ref   1.3[e](#T3FN5){ref-type="table-fn"}   1.3[e](#T3FN5){ref-type="table-fn"}
  (1.0--1.2)                                                                (0.6--0.8)                            (1.1--1.4)                             (1.0--1.4)    (1.1--1.4)                            (1.1--1.5)                                                                        
  Special diets                                                                                                                                                                                                                                                                                
  Ref                                                                       1.5[e](#T3FN5){ref-type="table-fn"}   1.5[e](#T3FN5){ref-type="table-fn"}    Ref           1.5[e](#T3FN5){ref-type="table-fn"}   1.9[e](#T3FN5){ref-type="table-fn"}   Ref   1.5[e](#T3FN5){ref-type="table-fn"}   1.8[e](#T3FN5){ref-type="table-fn"}
  (1.2--1.8)                                                                (1.3--1.8)                            (1.2--1.9)                             (1.5--2.4)    (1.2--1.9)                            (1.5--2.4)                                                                        
  Homeopathy                                                                                                                                                                                                                                                                                   
  Ref                                                                       1.2[h](#T3FN8){ref-type="table-fn"}   1.0 [h](#T3FN8){ref-type="table-fn"}   Ref           1.3[h](#T3FN8){ref-type="table-fn"}   1.3[h](#T3FN8){ref-type="table-fn"}   Ref   1.3[h](#T3FN8){ref-type="table-fn"}   1.4[h](#T3FN8){ref-type="table-fn"}
  (1.0--1.6)                                                                (0.8--1.3)                            (1.0--1.6)                             (1.0--1.7)    (1.0--1.7)                            (1.0--1.8)                                                                        
  Acupuncture                                                                                                                                                                                                                                                                                  
  Ref                                                                       1.4[h](#T3FN8){ref-type="table-fn"}   1.5[e](#T3FN5){ref-type="table-fn"}    Ref           1.3[h](#T3FN8){ref-type="table-fn"}   1.6[h](#T3FN8){ref-type="table-fn"}   Ref   1.3[h](#T3FN8){ref-type="table-fn"}   1.8[e](#T3FN5){ref-type="table-fn"}
  (1.0--1.8)                                                                (1.2--1.9)                            (1.0--1.8)                             (1.2--2.1)    (1.0--1.8)                            (1.3--2.4)                                                                        
  Naturopathy                                                                                                                                                                                                                                                                                  
  Ref                                                                       1.2[h](#T3FN8){ref-type="table-fn"}   1.4[h](#T3FN8){ref-type="table-fn"}    Ref           1.3[h](#T3FN8){ref-type="table-fn"}   2.0[h](#T3FN8){ref-type="table-fn"}   Ref   1.4[h](#T3FN8){ref-type="table-fn"}   2.4[e](#T3FN5){ref-type="table-fn"}
  (0.9--1.8)                                                                (1.0--2.0)                            (0.9--2.0)                             (1.3--3.2)    (0.9--2.1)                            (1.5-- 3.8)                                                                       
  Traditional healers                                                                                                                                                                                                                                                                          
  Ref                                                                       0.8[h](#T3FN8){ref-type="table-fn"}   1.0[h](#T3FN8){ref-type="table-fn"}    Ref           1.1[h](#T3FN8){ref-type="table-fn"}   1.9[h](#T3FN8){ref-type="table-fn"}   Ref   1.1[h](#T3FN8){ref-type="table-fn"}   1.9[h](#T3FN8){ref-type="table-fn"}
  (0.5--1.3)                                                                (0.6--1.5)                            (0.6--1.9)                             (1.1--3.2)    (0.6--2.0)                            (1.1--3.2)                                                                        
  Craniosacral                                                                                                                                                                                                                                                                                 
  Ref                                                                       0.8[h](#T3FN8){ref-type="table-fn"}   1.2[h](#T3FN8){ref-type="table-fn"}    Ref           0.7[h](#T3FN8){ref-type="table-fn"}   1.2[h](#T3FN8){ref-type="table-fn"}   Ref   0.7[h](#T3FN8){ref-type="table-fn"}   1.4[h](#T3FN8){ref-type="table-fn"}
  (0.4--1.5)                                                                (0.7--2.0)                            (0.3--1.4)                             (0.6--2.7)    (0.4--1.5)                            (0.6--3.1)                                                                        
  Ayurvedic medicine                                                                                                                                                                                                                                                                           
  Ref                                                                       0.7[h](#T3FN8){ref-type="table-fn"}   0.5[h](#T3FN8){ref-type="table-fn"}    Ref           0.7[h](#T3FN8){ref-type="table-fn"}   0.6[h](#T3FN8){ref-type="table-fn"}   Ref   0.7[h](#T3FN8){ref-type="table-fn"}   0.6[h](#T3FN8){ref-type="table-fn"}
  (0.4-- 1.2)                                                               (0.3-- 1.0)                           (0.4-- 1.2)                            (0.3-- 1.3)   (0.4-- 1.3)                           (0.3--1.3)                                                                        

Abbreviations: CAM, complementary and alternative medicine; CI, confidence interval; RR, relative risk.

Each modality was run as a separate relative risk regression model.

Adjusted for age, sex, race, income, employment status, and education.

Adjusted for age, sex, race, income, employment status, education, body mass index, and marital status.

Values are β (95% CI).

*P* value \<.001 (α = .003 after Bonferroni adjustment for multiple comparisons).

Values are RR (95% CI).

*P* value \<.003 (α = .003 after Bonferroni adjustment for multiple comparisons).

*P* value \>.003 (α = .003 after Bonferroni adjustment for multiple comparisons).

For the CAM index, after adjustment, adults with multiple conditions used significantly more CAM therapies than adults with no chronic conditions. No collinearity between predictors was observed for the final adjusted models (data not shown). Sensitivity analyses, examining more conservative definitions of CAM, resulted in smaller β coefficients. However, these definitions showed the same overall relationship as the all-inclusive CAM index ([Table 3](#T3){ref-type="table"}).

Discussion
==========

Results from the 2012 National Health Interview Survey showed more than half of US adults had at least one chronic condition and over a third had 2 or more chronic conditions. Dietary supplements were used most commonly. In multivariable models we observed that adults with multiple conditions were more likely to report using multiple forms of CAM therapies within the previous 12 months.

Previous studies using the NHIS CAM questionnaire in 2002 and 2007 reported similar associations between specific chronic conditions and CAM use, but no prior analysis has examined use in 13 simultaneous chronic conditions ([@R6],[@R7],[@R10],[@R11],[@R27]). In 2002, adults with asthma ([@R7]), cancer ([@R6]), diabetes ([@R11]), and at least one of 5 specific chronic conditions (arthritis, cancer, cardiovascular disease, diabetes, and lung disease) ([@R27]) reported higher CAM use than people with no chronic conditions. A study examining both the 2002 and 2007 NHIS data set also found that among adults with diabetes, participants with functional limitations or 3 or more conditions were more likely to use CAM ([@R10]). These studies are similar to the results of our analyses, where adults with multiple conditions reported a higher likelihood of CAM use.

Our study differs from previously reported NHIS studies in the definition of chronic condition, the definition of CAM, and in the choice of statistical model. First, prior studies vary in their definitions of chronic conditions. Many of these studies examined singular chronic conditions or a limited number of chronic conditions. Our study has an inclusive definition of multiple chronic conditions. Second, our study examines specific CAM therapies as opposed to other studies, which have focused on combined variables for any CAM therapy. Last, previous studies used odds ratios as compared with risk ratios. The epidemiological convention for point estimates states that when prevalence is more than 10%, the odds ratio will show an overestimated measure of association in comparison to the risk ratio, so the risk ratio should be used ([@R28]). Risk ratios were used in this analysis because many of the specific CAM therapies were reported as being used by more than 10% of the population. Although one cannot compare the specific estimates, the general direction of the association is consistent between our analysis and previous analyses. Additionally, these studies report data from the 2002 and 2007 surveys, suggesting this study's results support an ongoing trend of CAM use in association with chronic conditions. To our knowledge, this is the first study to examine the likelihood of specific CAM modality use by multiple chronic conditions as defined by DHHS ([@R4]).

A major strength of this study is the examination of CAM use as separate therapies. CAM is a group of separate behaviors that have differing intensity, effectiveness, and adverse effects. When these behaviors are combined into one overall CAM construct, information is lost regarding the direction of effect for specific therapies. Examining specific CAM therapies allowed us to parse out specific self-care and disease management behaviors among adults with chronic conditions. Our results showed that not all CAM therapies are associated with chronic conditions or multiple chronic conditions and further support the decision to examine CAM use as specific therapies rather than one overarching construct.

There are also limitations to note. First, the NHIS is a cross-sectional study, so temporality between chronic conditions and specific CAM use cannot be determined. One possibility is that chronic conditions influence people to use specific CAM therapies. Conversely, it is also possible that the CAM use precedes the development of a chronic condition. Second, there may be selection bias; the NHIS process excludes hospitalized and institutionalized people, causing an underestimation of adults with chronic illnesses as well as the most severe chronic conditions. This selection bias causes the sample to have proportionally more healthy people than are in the US population and more participants that have the ability to access CAM therapies, causing a bias toward the null. Third, both chronic disease status and CAM use is self-reported, resulting in potential misclassification and recall bias. Lastly, this data set does not include frequency of CAM modality use. If an individual used a modality once in the past year, they would be considered users, as would someone who uses these therapies weekly or daily. This causes an issue of determining what constitutes CAM behaviors. If the users who do not use a modality frequently in truth should be considered nonusers then there is nondifferential misclassification of outcome, biasing the association toward the null. In addition, there may be people with chronic conditions who discontinue CAM within the past year because of factors related to their disease status, which would overestimate the number of regular CAM users.

Multiple chronic conditions increase health care costs not only for the individual but also for the health care system. People with many conditions must navigate the health-care system to coordinate disease management, which often requires regular visits to different medical specialists. This increases the cost for the patient and health-care spending. People with multiple conditions account for approximately 66% of total health care costs ([@R3]). DHHS has created 4 goals to improve factors related to multiple chronic conditions, including changes to the health care system; empowering people with multiple conditions by creating community wellness programs; providing clinicians with education, training, and clinical practice guidelines; and improving research practices to include a focus on comorbid conditions as opposed to specific diseases ([@R29]).

Research on CAM use among people with comorbid conditions can provide information in support of the DHHS goals. The high use of dietary supplements among people with comorbid conditions is of major importance in disease management because of potential drug interactions. More research is needed to understand the efficacy of supplements and how they interact with standard chronic condition treatments. In addition, we observed high use of practitioner-based CAM. To improve disease management, an open dialogue between CAM practitioners and medical professionals could help improve decisions on care for patients with multiple chronic conditions. Additional research will help provide clinicians with evidence-based guidelines and lower health-care reimbursements. Therapies with an evidence base for improved health outcomes in this population could also be integrated into community wellness programs.

In summary, using data from a population-based sample of US adults, we found that adults with multiple chronic conditions have an increased likelihood of using specific types of CAM, including dietary supplements, mind--body therapies, chiropractic or osteopathic manipulation, massage, movement therapies, special diets, acupuncture, and naturopathy. Because adults with chronic conditions have an increased likelihood of using specific CAM therapies, in the face of unclear evidence, it is important to conduct CAM research on people with multiple chronic conditions and not only populations with specific diseases. Chronic condition management is an integral part in improving mortality and reducing illness among people with chronic conditions. Further research should focus on the efficacy of these therapies in individuals with multiple chronic conditions and on interactions with standard chronic disease treatments.
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